Create issue ticket

考えれる15県の原因 prok2

結果を表示する: English

  • ヒルシュスプルング病 D型-短指症候群

    [HSA: 2260 ] [KO: K04362 ] (HH3/KAL3) PROKR2 [HSA: 128674 ] [KO: K08380 ] (HH4/KAL4) PROK2 [HSA: 60675 ] (HH5/KAL5) CHD7 [HSA: 55636 ] [KO: K14437 ] (HH6/KAL6) FGF8 [HSA:[kegg.jp] 内分泌系疾患 hsa04912 GnRH signaling pathway hsa04080 Neuroactive ligand-receptor interaction hsa04810 Regulation of actin cytoskeleton (HH1/KAL1) KAL1 [HSA: 3730 ] (HH2/KAL2) FGFR1[kegg.jp]

  • 常染色体劣性痙性対麻痺 55型

    [HSA: 2260 ] [KO: K04362 ] (HH3/KAL3) PROKR2 [HSA: 128674 ] [KO: K08380 ] (HH4/KAL4) PROK2 [HSA: 60675 ] (HH5/KAL5) CHD7 [HSA: 55636 ] [KO: K14437 ] (HH6/KAL6) FGF8 [HSA:[kegg.jp] 内分泌系疾患 hsa04912 GnRH signaling pathway hsa04080 Neuroactive ligand-receptor interaction hsa04810 Regulation of actin cytoskeleton (HH1/KAL1) KAL1 [HSA: 3730 ] (HH2/KAL2) FGFR1[kegg.jp]

  • 常染色体劣性痙性対麻痺 48型

    [HSA: 2260 ] [KO: K04362 ] (HH3/KAL3) PROKR2 [HSA: 128674 ] [KO: K08380 ] (HH4/KAL4) PROK2 [HSA: 60675 ] (HH5/KAL5) CHD7 [HSA: 55636 ] [KO: K14437 ] (HH6/KAL6) FGF8 [HSA:[kegg.jp] 内分泌系疾患 hsa04912 GnRH signaling pathway hsa04080 Neuroactive ligand-receptor interaction hsa04810 Regulation of actin cytoskeleton (HH1/KAL1) KAL1 [HSA: 3730 ] (HH2/KAL2) FGFR1[kegg.jp]

  • 常染色体劣性痙性対麻痺 26型

    [HSA: 2260 ] [KO: K04362 ] (HH3/KAL3) PROKR2 [HSA: 128674 ] [KO: K08380 ] (HH4/KAL4) PROK2 [HSA: 60675 ] (HH5/KAL5) CHD7 [HSA: 55636 ] [KO: K14437 ] (HH6/KAL6) FGF8 [HSA:[kegg.jp] 内分泌系疾患 hsa04912 GnRH signaling pathway hsa04080 Neuroactive ligand-receptor interaction hsa04810 Regulation of actin cytoskeleton (HH1/KAL1) KAL1 [HSA: 3730 ] (HH2/KAL2) FGFR1[kegg.jp]

  • 常染色体劣性痙性対麻痺 21型

    [HSA: 2260 ] [KO: K04362 ] (HH3/KAL3) PROKR2 [HSA: 128674 ] [KO: K08380 ] (HH4/KAL4) PROK2 [HSA: 60675 ] (HH5/KAL5) CHD7 [HSA: 55636 ] [KO: K14437 ] (HH6/KAL6) FGF8 [HSA:[kegg.jp] 内分泌系疾患 hsa04912 GnRH signaling pathway hsa04080 Neuroactive ligand-receptor interaction hsa04810 Regulation of actin cytoskeleton (HH1/KAL1) KAL1 [HSA: 3730 ] (HH2/KAL2) FGFR1[kegg.jp]

  • 常染色体劣性痙性対麻痺 27型

    [HSA: 2260 ] [KO: K04362 ] (HH3/KAL3) PROKR2 [HSA: 128674 ] [KO: K08380 ] (HH4/KAL4) PROK2 [HSA: 60675 ] (HH5/KAL5) CHD7 [HSA: 55636 ] [KO: K14437 ] (HH6/KAL6) FGF8 [HSA:[kegg.jp] 内分泌系疾患 hsa04912 GnRH signaling pathway hsa04080 Neuroactive ligand-receptor interaction hsa04810 Regulation of actin cytoskeleton (HH1/KAL1) KAL1 [HSA: 3730 ] (HH2/KAL2) FGFR1[kegg.jp]

  • 常染色体劣性痙性対麻痺 20型

    [HSA: 2260 ] [KO: K04362 ] (HH3/KAL3) PROKR2 [HSA: 128674 ] [KO: K08380 ] (HH4/KAL4) PROK2 [HSA: 60675 ] (HH5/KAL5) CHD7 [HSA: 55636 ] [KO: K14437 ] (HH6/KAL6) FGF8 [HSA:[kegg.jp] 内分泌系疾患 hsa04912 GnRH signaling pathway hsa04080 Neuroactive ligand-receptor interaction hsa04810 Regulation of actin cytoskeleton (HH1/KAL1) KAL1 [HSA: 3730 ] (HH2/KAL2) FGFR1[kegg.jp]

  • 常染色体優性痙性対麻痺 8型

    [HSA: 2260 ] [KO: K04362 ] (HH3/KAL3) PROKR2 [HSA: 128674 ] [KO: K08380 ] (HH4/KAL4) PROK2 [HSA: 60675 ] (HH5/KAL5) CHD7 [HSA: 55636 ] [KO: K14437 ] (HH6/KAL6) FGF8 [HSA:[kegg.jp] 内分泌系疾患 hsa04912 GnRH signaling pathway hsa04080 Neuroactive ligand-receptor interaction hsa04810 Regulation of actin cytoskeleton (HH1/KAL1) KAL1 [HSA: 3730 ] (HH2/KAL2) FGFR1[kegg.jp]

  • 多発性内分泌腫瘍症 4型

    [HSA: 2260 ] [KO: K04362 ] (HH3/KAL3) PROKR2 [HSA: 128674 ] [KO: K08380 ] (HH4/KAL4) PROK2 [HSA: 60675 ] (HH5/KAL5) CHD7 [HSA: 55636 ] [KO: K14437 ] (HH6/KAL6) FGF8 [HSA:[kegg.jp] 内分泌系疾患 hsa04912 GnRH signaling pathway hsa04080 Neuroactive ligand-receptor interaction hsa04810 Regulation of actin cytoskeleton (HH1/KAL1) KAL1 [HSA: 3730 ] (HH2/KAL2) FGFR1[kegg.jp]

  • ミラー・ディーカー症候群

    [HSA: 2260 ] [KO: K04362 ] (HH3/KAL3) PROKR2 [HSA: 128674 ] [KO: K08380 ] (HH4/KAL4) PROK2 [HSA: 60675 ] (HH5/KAL5) CHD7 [HSA: 55636 ] [KO: K14437 ] (HH6/KAL6) FGF8 [HSA:[kegg.jp] 内分泌系疾患 hsa04912 GnRH signaling pathway hsa04080 Neuroactive ligand-receptor interaction hsa04810 Regulation of actin cytoskeleton (HH1/KAL1) KAL1 [HSA: 3730 ] (HH2/KAL2) FGFR1[kegg.jp]

さらなる症状